Financial Services · NSE: NIVABUPA
Niva Bupa Health Insurance Company
Q2 FY27 earnings and concall highlights
Q2 FY27 earnings call · Guided by management
Call held 4 Nov 2026 · Read the filing on NSEFiling
- M.Cap
- ₹14,322Cr
- P/E
- 109.5×
- 1Y return
- +1.12%
- From 52W high
- −15.3%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · standalone · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Last quarter | QoQ | |
|---|---|---|---|---|---|
| Net profit | 136 | -35 | — | — | — |
| EPS (₹) | 0.73 | — | — | — | — |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.
Guidance
Target of mid- to high-teens ROE; excess to be passed to customers
Vishwanath Mahendra · Executive Director and CFO · Q&A · p. 10
Target of mid- to high-teens ROE; excess to be passed to customers
“As we have mentioned earlier also, our target is to have mid- to high-teens ROE. So whatever is excess, we'll pass on to customer.”
Retail: October retail business grew in the 30s; management sees the trend continuing
Ankur Kharbanda · Executive Director and Deputy CEO · Q&A · p. 13
Retail: October retail business grew in the 30s; management sees the trend continuing
“But we still grew in the 30s in terms of our overall business -- retail business. And I see this trend continuing as well from here.”
In short
- 01H1 GWP excluding 1/n grew 26% to Rs 5,004 crore; retail grew 37% and is 77% of the book.
- 02H1 profit after tax on Ind AS basis was Rs 273 crore, up from Rs 132 crore.
- 03Management expects a combined ratio (CISR) of 98-99% and targets mid- to high-teens ROE.
- 04Retail business grew in the 30s in October and management sees the trend continuing.
- 05Solvency is 2.03x; no equity raise expected, Board approved debt raising up to Rs 500 crore.
- 06Investment yield of 7.4-7.5% is called sustainable for the foreseeable future.
- 07Management says attachment and Policybazaar business will continue under proposed commission caps.
Segments
Retail: Retail grew 37% excluding 1/n to about Rs 3,800 crore; retail is 77% of book
Krishnan Ramachandran · Managing Director and CEO · p. 4
Retail: Retail grew 37% excluding 1/n to about Rs 3,800 crore; retail is 77% of book
“Retail growth without 1/n is 37% and a number of INR3,800-odd crores. And on this basis, at this point, as of H1, 77% of our book is retail, up from the 75%-odd number that we had at the end of Q1.”
Retail health: Reported retail health growth in H1 was 47%
Krishnan Ramachandran · Managing Director and CEO · p. 3
Retail health: Reported retail health growth in H1 was 47%
“And Niva Bupa specifically for H1, our reported growth on retail health has been 47%.”
B2B: B2B business is about 7-8% of what the company does
Krishnan Ramachandran · Managing Director and CEO · Q&A · p. 7
B2B: B2B business is about 7-8% of what the company does
“That business is in the scheme of things, about 7%, 8% of what we do.”
Group: Group business has been flat or declining
Krishnan Ramachandran · Managing Director and CEO · Q&A · p. 11
Group: Group business has been flat or declining
“if I look at our group business overall, we have actually experienced flat or degrowth in that business.”
Employer-employee (SME): SME groups within employer-employee business growing
Bhabatosh Mishra · Chief Operating Officer · Q&A · p. 12
Employer-employee (SME): SME groups within employer-employee business growing
“Our proportion within the employee-employer groups, the SME groups continues to perform robustly with the growth.”
Demand
Distribution reforms expected to aid volume growth via price elasticity
Krishnan Ramachandran · Managing Director and CEO · p. 14
Distribution reforms expected to aid volume growth via price elasticity
“we have seen through GST that price elasticity of demand is very real. So regardless of where the level comes up with, clearly, we believe that volume growth and expansion of market will get a significant steer from whatever comes out.”
Lower commissions with steady prices expected to lift demand, as seen with GST
Ankur Kharbanda · Executive Director and Deputy CEO · Q&A · p. 12
Lower commissions with steady prices expected to lift demand, as seen with GST
“And the overall vision for the regulator is that when the price goes down or if the commission goes down, the price holds for some time, doesn't go up, that would mean the demand goes up, which we have seen in GST.”
Margins and costs
Expense of management at 34.7% vs 38% last year; allowed limit 36.1%
Vishwanath Mahendra · Executive Director and CFO · p. 4
Expense of management at 34.7% vs 38% last year; allowed limit 36.1%
“EoM has improved to 34.7% from 38% last year H1. The allowable EoM, including additional allowances, comes to 36.1%.”
Combined insurance service ratio improved 365 bps to 99.5% in H1
Vishwanath Mahendra · Executive Director and CFO · p. 4
Combined insurance service ratio improved 365 bps to 99.5% in H1
“Combined insurance service ratio for H1 has improved by 365 basis points to 99.5%.”
Retail: Retail loss ratio improved 77 bps to 67.4% in H1
Vishwanath Mahendra · Executive Director and CFO · p. 4
Retail: Retail loss ratio improved 77 bps to 67.4% in H1
“Retail loss ratio has also improved by 77 basis points to 67.4% in H1.”
Loss ratio gain partly from infections, more from writing high lifetime-value business
Vishwanath Mahendra · Executive Director and CFO · Q&A · p. 5
Loss ratio gain partly from infections, more from writing high lifetime-value business
“But the loss ratio improvement is driven, one, to some extent by this, but more about our philosophy of writing high LTV, LTV is lifetime value, business.”
Renewal book: Renewal book claims ratio run at about 75%
Krishnan Ramachandran · Managing Director and CEO · Q&A · p. 8
Renewal book: Renewal book claims ratio run at about 75%
“the number that we've been consistently talking about with respect to the claims ratio and the renewal book circa is 75%. We continue to run that book in that range only.”
Debt and working capital
Solvency ratio 2.03x on 30 September vs regulatory minimum 1.50
Vishwanath Mahendra · Executive Director and CFO · p. 4
Solvency ratio 2.03x on 30 September vs regulatory minimum 1.50
“Solvency ratio is at a healthy level of 2.03x as on 30th September against regulatory minimum of 1.50.”
Solvency is seasonal: lower in H1, profits come in H2 and Q4
Vishwanath Mahendra · Executive Director and CFO · Q&A · p. 10
Solvency is seasonal: lower in H1, profits come in H2 and Q4
“Under I-GAAP, the H1 is -- H1 has lower solvency on a like-to-like basis. The profits come in H2, especially on quarter 4.”
One-offs
No one-offs in loss ratio; pricing tied to overall combined ratio
Krishnan Ramachandran · Managing Director and CEO · Q&A · p. 13
No one-offs in loss ratio; pricing tied to overall combined ratio
“So I would say no one-offs, but steady, I would say, steady portfolio management is what you should continue to expect from us.”
Risks
Attachment: Attachment business volume seen holding or rising under commission cuts; value may fall
Ankur Kharbanda · Executive Director and Deputy CEO · Q&A · p. 12
Attachment: Attachment business volume seen holding or rising under commission cuts; value may fall
“So what we see is business remains as is, volume remains as is. In fact, volume goes up because of this, value probably may go down on this”
Policybazaar: Policybazaar growth may slow under new norms but stay at market growth rate
Ankur Kharbanda · Executive Director and Deputy CEO · Q&A · p. 12
Policybazaar: Policybazaar growth may slow under new norms but stay at market growth rate
“Their business overall, probably the growth may come down, but their business will still be going on at a market growth rate what it is today.”
Regulator expected to move solvency to risk-based capital aligned with Ind AS
Vishwanath Mahendra · Executive Director and CFO · Q&A · p. 10
Regulator expected to move solvency to risk-based capital aligned with Ind AS
“And what we understand from various discussion we had with the regulator, at some point in time, it will move to risk-based capital, which will align with Ind AS.”
Attachment: Attachment product seen relevant even if commission falls; pricing may change
Ankur Kharbanda · Executive Director and Deputy CEO · Q&A · p. 12
Attachment: Attachment product seen relevant even if commission falls; pricing may change
“So from an overall business point of view, we feel that even if the commission goes down, the product remains relevant and an important one for all of them to use that. Pricing may change, will be more product innovation, et cetera, et cetera, will also happen there.”
Other
H1 GWP excluding 1/n grew 26% to Rs 5,004 crore
Krishnan Ramachandran · Managing Director and CEO · p. 4
H1 GWP excluding 1/n grew 26% to Rs 5,004 crore
“as far as our overall numbers without 1/n is concerned, we've grown 26% to reach INR5,004 crores in terms of GWP.”
H1 profit after tax on Ind AS basis Rs 273 crore, up from Rs 132 crore
Krishnan Ramachandran · Managing Director and CEO · p. 4
H1 profit after tax on Ind AS basis Rs 273 crore, up from Rs 132 crore
“so our profit after tax on an Ind AS basis closed at INR273 crores, up from INR132 crores same period last year.”
Retail: Retail market share rose to 11% from 9.9% a year earlier
Krishnan Ramachandran · Managing Director and CEO · p. 4
Retail: Retail market share rose to 11% from 9.9% a year earlier
“Our retail market share improved to 11%, up from 9.9% same period last year.”
Claims settlement rate 95.6% in H1, up from 94.6%
Krishnan Ramachandran · Managing Director and CEO · p. 4
Claims settlement rate 95.6% in H1, up from 94.6%
“On claims settlement rate, we closed H1 at 95.6%, up from 94.6%.”
Blended NPS rose to 63 from 57
Krishnan Ramachandran · Managing Director and CEO · p. 4
Blended NPS rose to 63 from 57
“On NPS, same period last year, we improved our blended NPS to 63, up from 57 last year.”
Sources
- Earnings call transcript, Q2 FY27 Filed 10 Nov 2026 · 14 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

